(R)-3-Methyl-1-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)butan-1-aMine hydrochloride
Intermediate of Bortezomib for the treatment of myelomatosis
We can provide high-quality (R)-3-Methyl-1-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)butan-1-aMine hydrochloride and its derived impurities.
-
CAS1243174-57-3
-
CatalogHY-23960
-
Molecular Weight249.59
-
Molecular FormularC11H25BClNO2